$JBL

The electrical equipment sector is driven by AI infrastructure and electrification trends, with $50B+ annual grid investments through 2030. Key companies like GE Vernova (GEV), Amphenol (APH), and TE Connectivity (TEL) show varying fundamentals. TE Connectivity is highlighted as undervalued with a 19.9x P/E, 20.5% fair value upside, and strong cash flow.

Corning (GLW) fell 12.7% after announcing a $2B stock sale plan. Baldwin Insurance (BWIN) rose 7.9% on a $7.7B private equity deal. Gartner (IT) gained 7.7% at its tech conference. Jabil (JBL) dropped 5.1% on a lowered price target. Accenture (ACN) rose 5.2% after a price target increase.

Jabil Inc (JBL) shares fell 6.1% on September 14, 2026, closing at $298.72. GuruFocus estimates the stock is 50.2% overvalued, with a GF Value™ of $198.89. The company has a GF Score™ of 88/100, indicating strong profitability and growth but weak valuation. Insiders have sold $79.8M more than they bought in the past year. The P/E ratio is 37.3x, significantly above its 5-year median of 14.2x.

Jabil (JBL) shares fell 5.1% after Goldman Sachs lowered its price target to $375, citing a more cautious valuation. The stock is volatile, down 22% from its 52-week high, but up 25.1% year-to-date. Higher bond yields and oil prices pose risks for the company.

Jabil Inc. (JBL) stock rose 5.65% after strong earnings guidance. Goldman Sachs, while cutting its target to $375, expects 50% AI revenue growth and 6% EBIT margins. JBL reported $8.75B revenue, $275M net income, and 3% profit margin. The stock is in an uptrend, with support at $300 and resistance around $340.

Jabil Inc. (JBL) reported 12% year-over-year revenue growth to $8.8B in Q3 2026, with a core operating margin of 5.8%. The company credits its global supply chain network for resilience amid geopolitical and trade uncertainties. Competitors like Celestica (CLS) and Flex Ltd. (FLEX) also benefit from diversified manufacturing networks. JBL's stock has gained 45.3% over the past year, trading at a forward P/E of 18.65.

Analysts updated ratings and price targets for several companies. Amgen (AMGN) was downgraded to market perform with a $450 target. Equifax (EFX) was upgraded to outperform with a raised target to $245. Lockheed Martin (LMT) was upgraded to buy with a target raised to $674. Other companies include Eaton (ETN), Marvell (MRVL), Sensata (ST), Synopsys (SNPS), Amphenol (APH), Cdw (CDW), Jabil (JBL), Marathon Petroleum (MPC), Phillips 66 (PSX), and Valero Energy (VLO).

Jabil Inc. (JBL) has risen 36.2% year-to-date, outperforming its industry and the S&P 500. The company expects AI-related revenues to reach $13.6B in fiscal 2026, up from $9B in 2025, and is expanding manufacturing capacity to meet demand. JBL also sees growth in healthcare, renewable energy, and digital commerce sectors, but faces supply chain and competition challenges.

The FDA issued a warning to Jabil's Pharmaceutics International facility, citing significant violations of sterile drug manufacturing practices, including fungal contamination and weak quality oversight. This raises concerns about Jabil's ability to manufacture sterile products and could impact its pharmaceutical expansion plans. Jabil's 2026 revenue guidance of $35 billion includes contributions from healthcare and pharma, which may now be questioned by investors.

Jabil Inc. (JBL), a $33.8B electronic manufacturing services provider, reported Q3 2026 adjusted EPS of $3.16 and revenue of $8.75B, exceeding expectations. The company raised its fiscal 2026 guidance, citing strong AI data-center demand and new partnerships. Shares have surged 58.6% over 52 weeks, outperforming the S&P 500. Analysts rate it a 'Strong Buy' with a mean price target of $451.18.